Nombre,Factor,Categoria,Indice-H,Cantidad-articulos-ultimo,Cantidad-articulos-ultimos-tres,Enlace,ISSN,Homologacion
Pharmacological Reviews,7.179 ,Q1,221,22,72,http://pharmrev.aspetjournals.org/,0031-6997/1521-0081,A1
Nature Reviews Drug Discovery,7.018 ,Q1,309,188,786,https://www.nature.com/nrd/,1474-1776/1474-1784,A1
Nano Today,6.198 ,Q1,131,60,150,https://www.journals.elsevier.com/nano-today/,1748-0132/1878-044X,A1
Annual Review of Pharmacology and Toxicology,5.153 ,Q1,197,29,92,https://www.annualreviews.org/journal/pharmtox,Sin informacion,No
Perspectives in Medicinal Chemistry,4.450 ,Q1,16,0,2,https://journals.sagepub.com/home/pmd,Sin informacion,No
Trends in Pharmacological Sciences,4.195 ,Q1,211,101,286,https://www.cell.com/trends/pharmacological-sciences/home,0165-6147/1873-3735,A1
Journal for ImmunoTherapy of Cancer,4.194 ,Q1,45,357,350,https://jitc.biomedcentral.com/,2051-1426,A1
Advanced Drug Delivery Reviews,4.082 ,Q1,297,169,513,https://www.journals.elsevier.com/advanced-drug-delivery-reviews,0169-409X/1872-8294,A1
Drug Resistance Updates,3.920 ,Q1,105,17,67,http://www.elsevier.com/wps/find/journaldescription.cws_home/623026/description#description,1368-7646/1532-2084,A1
Molecular Therapy,3.489 ,Q1,168,223,777,https://www.cell.com/molecular-therapy-family/home,1525-0016/1525-0024,A1
Natural Product Reports,3.421 ,Q1,168,111,218,https://www.rsc.org/journals-books-databases/about-journals/npr/,0265-0568/1460-4752,A1
Pharmacology and Therapeutics,3.348 ,Q1,193,149,433,https://www.journals.elsevier.com/pharmacology-and-therapeutics,0163-7258/1879-016X,A1
Cell Chemical Biology,3.283 ,Q1,175,184,535,https://www.cell.com/cell-chemical-biology/home,2451-9448/2451-9456,A1
Neuropsychopharmacology,3.122 ,Q1,214,327,958,https://www.nature.com/npp/,0893-133X/1740-634X,A1
Cellular and Molecular Life Sciences,2.970 ,Q1,210,431,890,https://www.springer.com/journal/18,1420-682X/1420-9071,A1
Protein & Cell,2.827 ,Q1,54,115,316,https://www.springer.com/journal/13238,Sin informacion,No
Pain,2.563 ,Q1,250,310,1023,https://journals.lww.com/pain/pages/default.aspx,0304-3959/1872-6623,A1
British Journal of Pharmacology,2.493 ,Q1,202,369,959,http://www3.interscience.wiley.com/journal/121548564/home,0007-1188/1476-5381,A1
npj Vaccines,2.465 ,Q1,15,54,107,https://www.nature.com/npjvaccines/,2059-0105,A1
Medicinal Research Reviews,2.385 ,Q1,126,86,124,https://onlinelibrary.wiley.com/journal/10981128,0198-6325/1098-1128,A1
Theranostics,2.348 ,Q1,80,563,1011,https://www.thno.org/,1838-7640,A1
Journal of Antimicrobial Chemotherapy,2.230 ,Q1,185,600,1718,https://academic.oup.com/jac,0305-7453/1460-2091,A1
Journal of Controlled Release,2.230 ,Q1,256,483,1546,https://www.journals.elsevier.com/journal-of-controlled-release,0168-3659/1873-4995,A1
Neurotherapeutics,2.230 ,Q1,108,119,281,https://www.springer.com/journal/13311,1878-7479/1933-7213,A1
Emerging Microbes and Infections,2.212 ,Q1,38,172,415,https://www.tandfonline.com/toc/temi20/current,2222-1751,A1
Nucleic Acid Therapeutics,2.176 ,Q1,63,39,119,https://home.liebertpub.com/publications/nucleic-acid-therapeutics/601/overview,2159-3337/2159-3345,A1
PLoS Neglected Tropical Diseases,2.148 ,Q1,121,743,2658,https://journals.plos.org/plosntds/,1935-2727/1935-2735,A1
Advanced healthcare materials,2.135 ,Q1,74,353,998,https://onlinelibrary.wiley.com/journal/21922659,2192-2640/2192-2659,A1
Antimicrobial Agents and Chemotherapy,2.135 ,Q1,247,806,2968,https://aac.asm.org/,0066-4804/1098-6596,A1
Journal of Medicinal Chemistry,2.093 ,Q1,251,744,2247,https://pubs.acs.org/journal/jmcmar,0022-2623/1520-4804,A1
Molecular Therapy - Nucleic Acids,2.089 ,Q1,50,293,504,https://www.cell.com/molecular-therapy-family/home,Sin informacion,No
npj Systems Biology and Applications,2.043 ,Q1,14,43,99,https://www.nature.com/npjsba/,2056-7189,A1
"Nanotechnology, Science and Applications",2.004 ,Q1,26,5,23,https://www.dovepress.com/nanotechnology-science-and-applications-journal,Sin informacion,No
Journal of Molecular Medicine,2.003 ,Q1,134,137,369,https://www.springer.com/journal/109,0946-2716/1432-1440,A1
Emerging Contaminants,1.993 ,Q1,14,33,49,https://www.sciencedirect.com/journal/emerging-contaminants,2405-6642/2405-6650,A1
Current Opinion in Pharmacology,1.989 ,Q1,127,113,338,https://www.sciencedirect.com/journal/current-opinion-in-pharmacology,1471-4892/1471-4973,A1
Clinical Pharmacology and Therapeutics,1.986 ,Q1,183,418,729,https://ascpt.onlinelibrary.wiley.com/journal/15326535,0009-9236/1532-6535,A1
Environmental Pollution,1.968 ,Q1,211,1627,3541,https://www.journals.elsevier.com/environmental-pollution,0269-7491/1873-6424,A1
Particle and Fibre Toxicology,1.922 ,Q1,92,48,169,https://particleandfibretoxicology.biomedcentral.com/,1743-8977,A1
Drug and Alcohol Dependence,1.909 ,Q1,158,507,1356,https://www.sciencedirect.com/journal/drug-and-alcohol-dependence,0376-8716/1879-0046,A1
Drug Discovery Today,1.896 ,Q1,167,263,620,https://www.sciencedirect.com/journal/drug-discovery-today,1359-6446/1878-5832,A1
Current Opinion in Systems Biology,1.809 ,Q1,12,76,193,https://www.sciencedirect.com/journal/current-opinion-in-systems-biology,2452-3100,A1
Acta Pharmaceutica Sinica B,1.792 ,Q1,39,129,256,https://www.journals.elsevier.com/acta-pharmaceutica-sinica-b/,2211-3835/2211-3843,A1
Journal of Toxicology and Environmental Health - Part B: Critical Reviews,1.766 ,Q1,78,9,63,https://www.tandfonline.com/loi/uteb20,Sin informacion,No
Expert Review of Vaccines,1.746 ,Q1,81,103,358,https://www.tandfonline.com/toc/ierv20/current,1476-0584/1744-8395,A1
Vaccines,1.743 ,Q1,29,209,182,https://www.mdpi.com/journal/vaccines,2076-393X,A1
Progress in Neuro-Psychopharmacology and Biological Psychiatry,1.714 ,Q1,123,279,652,https://www.journals.elsevier.com/progress-in-neuro-psychopharmacology-and-biological-psychiatry,Sin informacion,No
Expert Opinion on Therapeutic Targets,1.699 ,Q1,83,92,320,https://www.tandfonline.com/loi/iett20,1472-8222/1744-7631,A1
International Journal of Neuropsychopharmacology,1.695 ,Q1,101,59,381,https://academic.oup.com/ijnp,1461-1457/1469-5111,A1
European Neuropsychopharmacology,1.652 ,Q1,107,136,448,https://www.journals.elsevier.com/european-neuropsychopharmacology,0924-977X/1873-7862,A1
Neuropharmacology,1.638 ,Q1,159,408,1389,https://www.sciencedirect.com/journal/neuropharmacology,0028-3908/1873-7064,A1
Reviews of Physiology Biochemistry and Pharmacology,1.618 ,Q1,62,0,19,https://www.springer.com/series/112,Sin informacion,No
Pharmacological Research,1.609 ,Q1,126,418,1063,https://www.journals.elsevier.com/pharmacological-research,1043-6618/1096-1186,A1
Antiviral Research,1.596 ,Q1,115,210,685,https://www.journals.elsevier.com/antiviral-research,0166-3542/1872-9096,A1
Human Genomics,1.594 ,Q1,50,69,123,https://humgenomics.biomedcentral.com/,1473-9542/1479-7364,A1
Handbook of Experimental Pharmacology,1.559 ,Q1,85,125,318,https://www.springer.com/series/164,Sin informacion,No
Addictive Behaviors,1.558 ,Q1,120,450,997,https://www.journals.elsevier.com/addictive-behaviors,0306-4603/1873-6327,A1
"Journal of immunotherapy (Hagerstown, Md. : 1997)",1.557 ,Q1,87,50,144,https://journals.lww.com/immunotherapy-journal/pages/default.aspx,Sin informacion,No
Topics in antiviral medicine,1.554 ,Q1,42,20,49,https://www.iasusa.org/activities/topics-in-antiviral-medicine/current-issues/,2161-5853/2161-5861,A1
Addiction Biology,1.551 ,Q1,74,207,364,https://onlinelibrary.wiley.com/journal/13691600,1355-6215/1369-1600,A1
Clinical Trials,1.549 ,Q1,58,101,258,https://journals.sagepub.com/home/ctj,1740-7745/1740-7753,A1
Current Neuropharmacology,1.531 ,Q1,65,85,317,https://benthamscience.com/journals/current-neuropharmacology/,1570-159X/1875-6190,A1
Molecular Pharmacology,1.517 ,Q1,194,150,429,http://molpharm.aspetjournals.org/,0026-895X/1521-0111,A1
Biochemical Pharmacology,1.509 ,Q1,192,323,927,https://www.journals.elsevier.com/biochemical-pharmacology,0006-2952/1873-2968,A1
Investigational New Drugs,1.493 ,Q1,83,210,318,https://www.springer.com/journal/10637/,0167-6997/1573-0646,A1
PharmacoEconomics,1.453 ,Q1,97,134,358,https://www.springer.com/journal/40273,1170-7690/1179-2027,A1
Applied and Translational Genomics,1.423 ,Q1,16,0,32,https://www.journals.elsevier.com/applied-and-translational-genomics,Sin informacion,No
Clinical Pharmacokinetics,1.417 ,Q1,157,141,364,https://www.springer.com/journal/40262,0312-5963/1179-1926,A1
Archives of Toxicology,1.379 ,Q1,103,272,809,https://www.springer.com/journal/204,0340-5761/1432-0738,A1
British Journal of Clinical Pharmacology,1.378 ,Q1,137,363,925,https://bpspubs.onlinelibrary.wiley.com/journal/13652125,0306-5251/1365-2125,A1
"Nanomedicine: Nanotechnology, Biology, and Medicine",1.372 ,Q1,116,222,687,https://www.journals.elsevier.com/nanomedicine-nanotechnology-biology-and-medicine,Sin informacion,No
Cardiovascular Drugs and Therapy,1.360 ,Q1,66,81,204,https://www.springer.com/journal/10557,0920-3206/1573-7241,A1
F1000Research,1.357 ,Q1,45,777,2299,https://f1000research.com/,2046-1402,A1
Journal of Psychopharmacology,1.342 ,Q1,112,151,438,https://journals.sagepub.com/home/jop,0269-8811/1461-7285,A1
Nanotoxicology,1.340 ,Q1,78,87,330,https://www.tandfonline.com/toc/inan20/current,1743-5390/1743-5404,A1
Journal of Nanobiotechnology,1.335 ,Q1,67,126,279,https://jnanobiotechnology.biomedcentral.com/,1477-3155,A1
Journal of Studies on Alcohol and Drugs,1.317 ,Q1,122,93,385,https://www.jsad.com/,1937-1888/1938-4114,A1
BioDrugs,1.304 ,Q1,63,65,159,https://www.springer.com/journal/40259,1173-8804/1179-190X,A1
Cancer Nanotechnology,1.299 ,Q1,21,11,32,https://cancer-nano.biomedcentral.com/,1868-6958/1868-6966,A1
Journal of Analytical Toxicology,1.297 ,Q1,74,107,320,http://www.jatox.com/index.php/vmchk.html,0146-4760/1945-2403,A1
Clinical Cancer Drugs,1.287 ,Q1,4,0,1,https://benthamscience.com/journals/clinical-cancer-drugs/,Sin informacion,No
Nanotheranostics,1.271 ,Q1,12,24,65,https://www.ntno.org/,2206-7418,A1
Altex,1.270 ,Q1,47,68,131,https://www.springer.com/journal/12270,1868-596X/1868-8551,A1
Bioconjugate Chemistry,1.266 ,Q1,168,314,1101,https://pubs.acs.org/journal/bcches,1043-1802/1520-4812,A1
EPMA Journal,1.263 ,Q1,29,36,97,https://www.springer.com/journal/13167,1878-5077/1878-5085,A1
International Journal for Parasitology: Drugs and Drug Resistance,1.257 ,Q1,31,51,155,https://www.sciencedirect.com/journal/international-journal-for-parasitology-drugs-and-drug-resistance,Sin informacion,No
Biomarker Insights,1.253 ,Q1,28,16,72,https://journals.sagepub.com/home/bmi,1177-2719,A1
Psychopharmacology,1.253 ,Q1,190,308,957,https://www.springer.com/journal/213,0033-3158/1432-2072,A1
Alcoholism: Clinical and Experimental Research,1.246 ,Q1,150,267,780,https://onlinelibrary.wiley.com/journal/15300277,Sin informacion,No
Pharmaceuticals,1.245 ,Q1,50,184,309,http://www.mdpi.com/journal/pharmaceuticals/,1424-8247,A1
Clinical and Experimental Vaccine Research,1.243 ,Q1,9,18,39,https://www.ecevr.org/,2287-3651/2287-366X,A1
CNS Neuroscience and Therapeutics,1.241 ,Q1,64,152,365,https://onlinelibrary.wiley.com/journal/17555949,1755-5930/1755-5949,A1
Therapeutic Advances in Neurological Disorders,1.240 ,Q1,44,74,161,https://us.sagepub.com/en-us/nam/therapeutic-advances-in-neurological-disorders/journal201898,1756-2856/1756-2864,A1
Cancer Chemotherapy and Pharmacology,1.239 ,Q1,105,261,786,https://www.springer.com/journal/280,0344-5704/1432-0843,A1
Journal of NeuroImmune Pharmacology,1.235 ,Q1,66,94,174,https://www.springer.com/journal/11481,1557-1890/1557-1904,A1
Frontiers in Pharmacology,1.228 ,Q1,71,1430,2887,https://www.frontiersin.org/journals/pharmacology,1663-9812,A1
Pharmaceutical Statistics,1.223 ,Q1,36,69,166,https://onlinelibrary.wiley.com/journal/15391612,1539-1604/1539-1612,A1
Cell Biology and Toxicology,1.216 ,Q1,59,61,124,https://www.springer.com/journal/10565,0742-2091/1573-6822,A1
Molecular Pharmaceutics,1.213 ,Q1,120,469,1400,https://pubs.acs.org/journal/mpohbp,1543-8384/1543-8392,A1
Acta Pharmacologica Sinica,1.195 ,Q1,84,184,509,https://www.nature.com/aps/,1671-4083/1745-7254,A1
Expert Opinion on Investigational Drugs,1.180 ,Q1,101,103,365,https://www.tandfonline.com/loi/ieid20,1354-3784/1744-7658,A1
Clinical and Translational Science,1.175 ,Q1,39,92,185,https://ascpt.onlinelibrary.wiley.com/journal/17528062,1752-8054/1752-8062,A1
Toxicological Sciences,1.175 ,Q1,175,234,833,https://academic.oup.com/toxsci,1096-0929/1096-6080,A1
Antibiotics,1.173 ,Q1,26,267,187,https://www.mdpi.com/journal/antibiotics,2079-6382,A1
Journal of Natural Products,1.165 ,Q1,132,424,1185,https://pubs.acs.org/journal/jnprdf,0163-3864/1520-6025,A1
Drug Discovery Today: Technologies,1.162 ,Q1,45,14,105,https://www.sciencedirect.com/journal/drug-discovery-today-technologies,Sin informacion,No
Expert Opinion on Drug Discovery,1.160 ,Q1,56,113,319,https://www.tandfonline.com/loi/iedc20,1746-0441/1746-045X,A1
ACS Medicinal Chemistry Letters,1.158 ,Q1,60,305,700,https://pubs.acs.org/journal/amclct,1948-5875,A1
Drug Safety,1.148 ,Q1,120,134,361,https://www.springer.com/journal/40264,0114-5916/1179-1942,A1
Journal of Pharmacology and Experimental Therapeutics,1.148 ,Q1,219,265,681,http://jpet.aspetjournals.org/,0022-3565/1521-0103,A1
European Journal of Medicinal Chemistry,1.144 ,Q1,151,969,2631,https://www.journals.elsevier.com/european-journal-of-medicinal-chemistry/,0223-5234/1768-3254,A1
Journal of Cardiovascular Translational Research,1.143 ,Q1,48,108,163,https://www.springer.com/journal/12265,1937-5387/1937-5395,A1
Apoptosis : an international journal on programmed cell death,1.127 ,Q1,107,83,301,https://www.springer.com/journal/10495,Sin informacion,No
Vascular Pharmacology,1.121 ,Q1,91,80,254,https://www.journals.elsevier.com/vascular-pharmacology,1537-1891/1879-3649,A1
Drug Metabolism Reviews,1.119 ,Q1,95,32,79,https://www.tandfonline.com/toc/idmr20/current,0360-2532/1097-9883,A1
Cancer Biology and Therapy,1.116 ,Q1,108,156,425,https://www.tandfonline.com/toc/kcbt20/current,1538-4047/1555-8576,A1
Journal of managed care & specialty pharmacy,1.113 ,Q1,60,170,449,https://www.jmcp.org/,Sin informacion,No
Critical Reviews in Toxicology,1.107 ,Q1,107,39,133,https://www.tandfonline.com/loi/itxc20,1040-8444/1547-6898,A1
Drug Metabolism and Disposition,1.097 ,Q1,169,169,602,http://dmd.aspetjournals.org/,0090-9556/1521-009X,A1
Cannabis and Cannabinoid Research,1.095 ,Q1,13,31,67,https://www.scimagojr.com/journalsearch.php?q=21100892509&tip=sid&clean=0,2378-8763,A1
Human Vaccines and Immunotherapeutics,1.088 ,Q1,50,488,1291,https://www.tandfonline.com/toc/khvi20/current,2164-5515/2164-554X,A1
International Journal of Pharmaceutics,1.081 ,Q1,204,887,2518,https://www.journals.elsevier.com/international-journal-of-pharmaceutics,0378-5173/1873-3476,A1
Journal of Exposure Science and Environmental Epidemiology,1.077 ,Q1,87,121,228,https://www.nature.com/jes/,1559-0631/1559-064X,A1
Drug Delivery,1.072 ,Q1,57,129,760,https://www.tandfonline.com/toc/idrd/current,1071-7544/1521-0464,A1
International Journal of Nanomedicine,1.061 ,Q1,114,721,1755,https://www.dovepress.com/international-journal-of-nanomedicine-journal,1176-9114/1178-2013,A1
European Journal of Pharmaceutics and Biopharmaceutics,1.059 ,Q1,150,268,847,https://www.journals.elsevier.com/european-journal-of-pharmaceutics-and-biopharmaceutics,0939-6411/1873-3441,A1
Core Evidence (discontinued),1.054 ,Q1,22,0,10,https://www.dovepress.com/core-evidence-journal,Sin informacion,No
Biomedicine and Pharmacotherapy,1.050 ,Q1,85,1431,4201,https://www.journals.elsevier.com/biomedicine-and-pharmacotherapy,0753-3322/1950-6007,A1
Journal of Food and Drug Analysis,1.043 ,Q1,47,92,371,https://www.journals.elsevier.com/journal-of-food-and-drug-analysis/,1021-9498,A1
Toxins,1.034 ,Q1,66,759,1334,https://www.mdpi.com/journal/toxins,2072-6651,A1
Life Sciences,1.031 ,Q1,156,910,1504,http://www.elsevier.com/wps/find/journaldescription.cws_home/525477/description#description,0024-3205/1879-0631,A1
Toxicology,1.029 ,Q1,153,173,499,http://www.elsevier.com/wps/find/journaldescription.cws_home/505518/description#description,0300-483X/1879-3185,A1
Expert Opinion on Therapeutic Patents,1.027 ,Q1,66,74,295,http://www.tandfonline.com/toc/ietp20/current,1354-3776/1744-7674,A1
PPAR Research,1.025 ,Q1,44,16,79,https://www.hindawi.com/journals/ppar/,1687-4757/1687-4765,A1
Chemical Research in Toxicology,1.002 ,Q1,149,264,584,https://pubs.acs.org/journal/crtoec,0893-228X/1520-5010,A1
Expert Opinion on Drug Delivery,1.001 ,Q1,98,107,366,https://www.tandfonline.com/toc/iedd20/current,1742-5247/1744-7593,A1
AAPS Journal,0.999 ,Q1,107,108,436,https://www.springer.com/journal/12248,1550-7416,A1
International Immunopharmacology,0.992 ,Q1,106,689,1291,http://www.elsevier.com/wps/find/journaldescription.cws_home/621330/description#description,1567-5769/1878-1705,A1
European Journal of Pharmacology,0.988 ,Q1,174,691,1699,http://www.elsevier.com/wps/find/journaldescription.cws_home/506087/description#description,0014-2999/1879-0712,A1
Clinical Therapeutics,0.981 ,Q1,130,237,701,http://www.clinicaltherapeutics.com/,0149-2918/1879-114X,A1
Pharmacogenomics Journal,0.981 ,Q1,83,96,255,http://www.nature.com/tpj/index.html,1470-269X/1473-1150,A1
Inflammation Research,0.980 ,Q1,86,99,297,http://www.springer.com/birkhauser/biosciences/journal/11,1023-3830/1420-908X,A1
Pharmacogenomics and Personalized Medicine,0.967 ,Q1,25,34,70,https://www.scimagojr.com/journalsearch.php?q=19700175029&tip=sid&clean=0,Sin informacion,No
Infection and Drug Resistance,0.966 ,Q1,32,394,359,https://www.dovepress.com/infection-and-drug-resistance-journal,1178-6973,A1
Results in Pharma Sciences,0.963 ,Q1,14,0,3,https://www.scimagojr.com/journalsearch.php?q=19900192163&tip=sid&clean=0,Sin informacion,No
Phytomedicine,0.958 ,Q1,113,484,660,http://www.elsevier.com/wps/find/journaldescription.cws_home/701794/description#description,0944-7113/1618-095X,A1
Pharmacology Research and Perspectives,0.953 ,Q1,24,95,230,https://www.wiley.com/en-us/Pharmacology+Research+%26+Perspectives-p-9780JRNL75675,2052-1707,A1
Toxicology and Applied Pharmacology,0.945 ,Q1,163,315,914,https://www.journals.elsevier.com/toxicology-and-applied-pharmacology,0041-008X/1096-0333,A1
NeuroToxicology,0.933 ,Q1,109,128,533,https://www.journals.elsevier.com/neurotoxicology,0161-813X/1872-9711,A1
Expert Opinion on Drug Metabolism and Toxicology,0.930 ,Q1,76,88,380,http://informahealthcare.com/loi/emt,1742-5255/1744-7607,A1
Toxicology Letters,0.928 ,Q1,137,250,909,http://www.elsevier.com/wps/find/journaldescription.cws_home/505519/description#description,0378-4274/1879-3169,A1
Biomolecules and Therapeutics,0.920 ,Q1,31,70,235,https://www.scimagojr.com/journalsearch.php?q=18800156730&tip=sid&clean=0,1976-9148/2005-4483,A1
Expert Opinion on Biological Therapy,0.917 ,Q1,83,131,445,http://informahealthcare.com/loi/ebt?ai=rw&af=R,1471-2598/1744-7682,A1
Neurotoxicology and Teratology,0.915 ,Q1,94,41,194,http://www.elsevier.com/wps/find/journaldescription.cws_home/525481/description#description,0892-0362/1872-9738,A1
Pharmaceutical Research,0.913 ,Q1,200,185,747,http://www.springer.com/biomed/pharmaceutical+science/journal/11095,0724-8741/1573-904X,A1
Clinical Toxicology,0.912 ,Q1,91,239,487,http://informahealthcare.com/loi/ctx,1556-3650/1556-9519,A1
Toxicology Reports,0.912 ,Q1,28,159,340,https://www.elsevier.com/journals/toxicology-reports/2214-7500/open-access-journal,2214-7500,A1
Current Medicinal Chemistry,0.903 ,Q1,167,432,881,https://benthamscience.com/journals/current-medicinal-chemistry/,0929-8673/1875-533X,A1
Food and Chemical Toxicology,0.902 ,Q1,159,691,1724,https://www.journals.elsevier.com/food-and-chemical-toxicology,0278-6915/1873-6351,A1
Drug Testing and Analysis,0.898 ,Q1,50,198,532,https://www.scimagojr.com/journalsearch.php?q=19700174958&tip=sid&clean=0,1942-7603/1942-7611,A1
Journal of Ethnopharmacology,0.898 ,Q1,181,614,1671,https://www.journals.elsevier.com/journal-of-ethnopharmacology,0378-8741/1872-7573,A1
Chemico-Biological Interactions,0.896 ,Q1,115,385,922,http://www.elsevier.com/wps/find/journaldescription.cws_home/505510/description#description,Sin informacion,No
ChemMedChem,0.895 ,Q1,96,196,829,http://www3.interscience.wiley.com/journal/110485305/home,1860-7179/1860-7187,A1
Pharmaceutics,0.894 ,Q1,39,688,381,https://www.mdpi.com/journal/pharmaceutics,1999-4923,A1
Current Cancer Drug Targets,0.893 ,Q1,89,81,230,https://benthamscience.com/journals/current-cancer-drug-targets/,1568-0096/1873-5576,A1
"Drug Design, Development and Therapy",0.880 ,Q1,54,388,1085,https://www.dovepress.com/drug-design-development-and-therapy-journal,Sin informacion,No
Journal of Pharmaceutical Analysis,0.829 ,Q1,24,55,170,https://www.journals.elsevier.com/journal-of-pharmaceutical-analysis,2095-1779/2214-0883,A1
Bioorganic Chemistry,0.819 ,Q1,55,792,661,https://www.sciencedirect.com/journal/bioorganic-chemistry,0045-2068/1090-2120,A1
Journal of Enzyme Inhibition and Medicinal Chemistry,0.808 ,Q1,68,171,625,http://informahealthcare.com/loi/enz,1475-6366/1475-6374,A1
BioImpacts,0.802 ,Q1,27,30,97,https://bi.tbzmed.ac.ir/,2228-5652/2228-5660,A1
European Journal of Pharmaceutical Sciences,0.802 ,Q1,128,343,1335,https://www.journals.elsevier.com/european-journal-of-pharmaceutical-sciences,0928-0987/1879-0720,A1
International Journal of Genomics,0.798 ,Q1,20,65,208,https://www.scimagojr.com/journalsearch.php?q=21100241624&tip=sid&clean=0,2314-436X/2314-4378,A1
Journal of Pharmaceutical and Biomedical Analysis,0.795 ,Q1,120,623,1980,http://www.elsevier.com/wps/find/journaldescription.cws_home/525434/description#description,0731-7085/1873-264X,A1
Patient Preference and Adherence,0.794 ,Q1,43,213,733,https://www.dovepress.com/patient-preference-and-adherence-journal,1177-889X,A1
Expert Review of Clinical Pharmacology,0.792 ,Q1,36,116,409,http://www.expert-reviews.com/loi/ecp,1751-2433/1751-2441,A1
Research in Social and Administrative Pharmacy,0.775 ,Q1,41,304,409,https://www.journals.elsevier.com/research-in-social-and-administrative-pharmacy,1551-7411/1934-8150,A1
Journal of Biomedical Nanotechnology,0.762 ,Q1,70,205,517,https://www.scimagojr.com/journalsearch.php?q=11700154733&tip=sid&clean=0,1550-7033/1550-7041,A1
OpenNano,0.756 ,Q1,7,5,19,https://www.journals.elsevier.com/opennano,2352-9520,A1
Journal of Pharmaceutical Sciences,0.755 ,Q1,169,431,1191,https://www.journals.elsevier.com/journal-of-pharmaceutical-sciences,0022-3549/1520-6017,A1
Journal of Drug Targeting,0.748 ,Q1,86,118,272,https://www.tandfonline.com/loi/idrt20,1029-2330/1061-186X,A1
Bioorganic and Medicinal Chemistry,0.739 ,Q1,154,487,1952,http://www.elsevier.com/wps/find/journaldescription.cws_home/129/description#description,0968-0896/1464-3391,A1
Journal of Aerosol Medicine and Pulmonary Drug Delivery,0.724 ,Q1,65,36,133,http://www.liebertpub.com/products/product.aspx?pid=24,1941-2703/1941-2711,A1
American Journal of Pharmaceutical Education,0.723 ,Q1,58,260,563,http://www.ajpe.org/volsIssues/issueViewer.asp?vol=74&issue=02&YR=2008%20,0002-9459/1553-6467,A1
Saudi Pharmaceutical Journal,0.700 ,Q1,42,148,433,https://www.journals.elsevier.com/saudi-pharmaceutical-journal/,1319-0164/2213-7475,A1
Molecules,0.698 ,Q1,131,4676,7509,https://www.mdpi.com/journal/molecules,1420-3049,A1
Statistics in Biopharmaceutical Research,0.692 ,Q1,12,67,128,https://www.scimagojr.com/journalsearch.php?q=21100209501&tip=sid&clean=0,1946-6315,A1
Asian Journal of Pharmaceutical Sciences,0.673 ,Q1,33,81,311,https://www.journals.elsevier.com/asian-journal-of-pharmaceutical-sciences,1818-0876/2221-285X,A1
Journal of Pharmaceutical Investigation,0.672 ,Q1,21,66,169,https://link.springer.com/journal/40005,2093-5552/2093-6214,A1
MedChemComm,0.666 ,Q1,49,194,707,https://www.rsc.org/journals-books-databases/about-journals/rsc-medicinal-chemistry/,Sin informacion,No
Pharmaceutical Biology,0.655 ,Q1,59,100,767,http://informahealthcare.com/phb,1388-0209/1744-5116,A1
International Journal of Clinical Pharmacy,0.654 ,Q1,57,202,524,https://www.springer.com/journal/11096,2210-7703/2210-7711,A1
Journal of Pharmaceutical Policy and Practice,0.644 ,Q1,16,35,102,https://www.scimagojr.com/journalsearch.php?q=21100325142&tip=sid&clean=0,2052-3211,A1
Bioorganic and Medicinal Chemistry Letters,0.640 ,Q1,141,609,2860,http://www.elsevier.com/wps/find/journaldescription.cws_home/972/description#description,0960-894X/1464-3405,A1
Critical Reviews in Therapeutic Drug Carrier Systems,0.639 ,Q1,71,13,44,http://www.begellhouse.com/journals/3667c4ae6e8fd136.html,0743-4863/2162-660X,A1
Bioanalysis,0.606 ,Q1,55,213,617,https://www.scimagojr.com/journalsearch.php?q=19700188217&tip=sid&clean=0,1757-6180/1757-6199,A1
Therapeutics and Clinical Risk Management,0.604 ,Q1,49,152,674,https://www.dovepress.com/therapeutics-and-clinical-risk-management-journal,1178-203X,B
Biomedical Reports,0.570 ,Q1,19,86,562,https://www.spandidos-publications.com/br,2049-9434/2049-9442,A1
Advanced Pharmaceutical Bulletin,0.569 ,Q1,29,80,242,https://apb.tbzmed.ac.ir/,2228-5881/2251-7308,A1
Brazilian Journal of Medical and Biological Research,0.539 ,Q1,83,152,506,http://www.scielo.br/scielo.php?script=sci_serial&pid=0100-879X&lng=en&nrm=iso,0100-879X/1414-431X,A1
Research in Pharmaceutical Sciences,0.533 ,Q1,24,60,176,http://rps.mui.ac.ir/index.php/jrps,1735-5362/1735-9414,A1
Advances in Pharmacological Sciences,0.531 ,Q1,27,22,56,https://www.hindawi.com/journals/aps/,1687-6334/1687-6342,A1
Journal of Zhejiang University: Science B,0.527 ,Q1,50,105,318,http://www.springer.com/biomed/journal/11585,Sin informacion,No
Value in Health Regional Issues,0.487 ,Q1,15,81,178,https://www.journals.elsevier.com/value-in-health-regional-issues,2212-1099/2212-1102,A1
